头颈癌高危亚组中及时术后放疗与生存的关联
基于美国国家癌症数据库2004-2020年的回顾性队列研究,纳入54,035例接受手术和术后放疗的HPV阴性头颈鳞癌患者,评估术后放疗延迟超过6周与总生存的关联。结果显示62%(33,491例)存在放疗延迟,黑人患者更易延迟(aOR 1.19,95%CI 1.10-1.27)。及时放疗仅与所有I期患者和白人IV期患者生存改善相关;校正协变量后,及时放疗在黑人IV期患者中估计与较差总生存相关但精度低。结论认为及时、符合指南的术后放疗可能无法减少黑人患者(尤其晚期)的生存差异。
要点
- 54,035例中62%存在术后放疗延迟超过6周,黑人患者延迟风险更高(aOR 1.19)。
- 及时放疗仅与所有I期患者和白人IV期患者生存改善相关。
- 校正后及时放疗在黑人IV期患者中估计与较差总生存相关但精度低。
核心结论
- 及时、符合指南的术后放疗可能无法减少黑人患者的生存差异,尤其晚期患者,提示需要其他干预措施来解决该差异。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库2004-2020年数据,纳入54,035例接受手术和术后放疗的HPV阴性头颈鳞状细胞癌患者。
主要发现
- 62%(33,491例)患者存在术后放疗延迟超过6周。
- 黑人患者更易出现术后放疗延迟(aOR 1.19,95%CI 1.10-1.27)。
- 及时术后放疗仅与所有I期患者和白人IV期患者生存改善相关(预测死亡风险2.53,95%CI 2.34-2.74 vs 2.88,95%CI 2.67-3.09,参照白人I期)。
- 校正协变量后,及时术后放疗在黑人IV期患者中估计与较差总生存相关但精度低(预测死亡风险3.24,95%CI 2.87-3.66 vs 2.71,95%CI 2.47-2.98,参照白人I期)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Effective implementation of timely postoperative radiation therapy (PORT) as a quality metric for head and neck squamous cell carcinoma (HNSCC) care may reduce survival disparities in subgroups with the highest risk of mortality-advanced stage and Black race. We sought to determine if the association between timely PORT and survival varies among clinical and demographic high-risk subgroups. METHODS: In this retrospective cohort study using the National Cancer Database 2004-2020, patients with HPV-negative HNSCC treated with surgery and PORT were identified. The association between PORT delay greater than 6 weeks with overall survival was assessed by Cox proportional hazards models with interaction effects for race, overall stage, and PORT delay. RESULTS: Among 54,035 patients included in the study, 62% (33491) had PORT delays. Black patients were more likely to have PORT delays (aOR 1.19, 95% CI: 1.10-1.27). Timely PORT was only associated with improved survival for all stage I patients and White stage IV patients (predicted mortality risk 2.53, 95% CI: 2.34-2.74 versus 2.88, 95% CI: 2.67-3.09, referenced to White, stage I). After adjusting for covariates, timely PORT was estimated to be associated with inferior overall survival in Black patients with stage IV disease although with low precision (predicted mortality risk 3.24, 95% CI: 2.87-3.66, versus 2.71, 95% CI: 2.47-2.98, referenced to White, stage I). CONCLUSION: Timely, guideline-adherent PORT may not reduce survival disparities in Black patients, especially those with advanced stage disease, suggesting other interventions are needed to address this disparity.
引用
- Velez Velez LM, Corpuz TV, Schwetschenau LC, et al. Survival Associations of Timely Postoperative Radiotherapy Among Head and Neck Cancer High-Risk Subgroups. Laryngoscope. 2025. PMID: 39960154. doi:10.1002/lary.32074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。